Literature DB >> 1656065

Regulation of early gene expression from the bovine papillomavirus genome in transiently transfected C127 cells.

P Szymanski1, A Stenlund.   

Abstract

Expression of bovine papillomavirus (BPV) early gene products is required for viral DNA replication and establishment of the transformed phenotype. By the use of a highly efficient electroporation system, we have examined for the first time the transcriptional activity of BPV promoters in their natural genomic context in a replication-permissive cell line. We have determined that a qualitatively distinct stage of transcription is not detectable prior to DNA replication in transiently transfected cells. This suggests that the transcriptional activity of the BPV genome in stably transformed cells represents the early stage of BPV gene expression. Quantitative differences in promoter activity between transiently transfected and stably transformed cells suggest that subtle changes in gene expression may control progression of the viral life cycle. Deletion analysis demonstrated that the E2 transactivator protein stimulates all of the early promoters through sequences located in the upstream regulatory region. This E2-dependent enhancer was found to be highly redundant, and particular E2 binding sites did not display a preference for particular promoters. Despite this dependence on a common cis-acting sequence, the various promoters displayed different sensitivities to the E2 transactivator. The findings that E2 regulates all promoters and, with the exception of the E2 repressors, that no other known viral gene product appears to affect transcription indicate that the E2 system functions as the master regulator of BPV early gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656065      PMCID: PMC250231     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.

Authors:  R Li; J D Knight; S P Jackson; R Tjian; M R Botchan
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

2.  Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.

Authors:  M Tanaka; W Herr
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

3.  Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity.

Authors:  D J Riese; J Settleman; K Neary; D DiMaio
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells.

Authors:  P F Lambert; N L Hubbert; P M Howley; J T Schiller
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  A quantitative in vitro focus assay for bovine papilloma virus.

Authors:  I Dvoretzky; R Shober; S K Chattopadhyay; D R Lowy
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

7.  Open reading frames E6 and E7 of bovine papillomavirus type 1 are both required for full transformation of mouse C127 cells.

Authors:  K Neary; D DiMaio
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

8.  Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants.

Authors:  P F Lambert; B C Monk; P M Howley
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  The E2 transactivator of bovine papillomavirus type 1 is expressed from multiple promoters.

Authors:  P Vaillancourt; T Nottoli; J Choe; M R Botchan
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

10.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  18 in total

1.  A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter.

Authors:  G L Bream; P Vaillancourt; M R Botchan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.

Authors:  M G McPhillips; J G Oliveira; J E Spindler; R Mitra; A A McBride
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle.

Authors:  Ivar Ilves; Kristina Mäemets; Toomas Silla; Kadri Janikson; Mart Ustav
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.

Authors:  M Ushikai; M J Lace; Y Yamakawa; M Kono; J Anson; T Ishiji; S Parkkinen; N Wicker; M E Valentine; I Davidson
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters.

Authors:  S K Barksdale; C C Baker
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions.

Authors:  H Sakai; T Yasugi; J D Benson; J J Dowhanick; P M Howley
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Repression of bovine papillomavirus type 1 transcription by the E1 replication protein.

Authors:  A B Sandler; S B Vande Pol; B A Spalholz
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.

Authors:  F Stubenrauch; I M Leigh; H Pfister
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.